Gitman Paul 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Sep 7, 2018

Insider Transaction Report

Form 4
Period: 2018-09-07
Gitman Paul
Director
Transactions
  • Sale

    Common Stock, $0.001 par value

    2018-09-07$57.64/sh1,000$57,63720,000 total

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES